Darian M. Bartkowski
Impact in
- Ophthalmology top 10%
- Retinal Diseases and Treatments
-
- Advanced Glycation End Products research
Papers in
-
- Retinal Development and Disorders 2
- Epigenetics and DNA Methylation 1
- Melanoma and MAPK Pathways 1
- Cancer therapeutics and mechanisms 1
- Retinoids in leukemia and cellular processes 1
-
- Retinal Diseases and Treatments 2
- Co-authors
- David C. Gale (2 shared papers)Timothy S. Kern (2 shared papers)Yunpeng Du (2 shared papers)Liliana N. Berti‐Mattera (1 shared paper)Michael R. Niesman (2 shared papers)Gordon Alton (2 shared papers)Jie Tang (2 shared papers)Chieh Allen Lee (1 shared paper)
- Journals
- Investigative Ophthalmology & Visual Science (2 papers)Nucleosides Nucleotides & Nucleic Acids (1 paper)Molecular Cancer Therapeutics (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Darian M. Bartkowski
5 papers receiving 202 citations
Peers
Comparison fields: 5 of 55
- Ophthalmology 35
- Clinical Biochemistry 15
- Hepatology 15
- Neurology 13
- Immunology 30
Countries citing papers authored by Darian M. Bartkowski
This map shows the geographic impact of Darian M. Bartkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darian M. Bartkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darian M. Bartkowski more than expected).
Fields of papers citing papers by Darian M. Bartkowski
This network shows the impact of papers produced by Darian M. Bartkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darian M. Bartkowski. The network helps show where Darian M. Bartkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Darian M. Bartkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 108 | |
| 2 | 2011 | 45 | |
| 3 | 2007 | 33 | |
| 4 | 2008 | 13 | |
| 5 | 2019 | 6 | |
| 6 | Inhibition of P38 Mapk Inhibits Early Stages of Diabetic Retinopathy | 2010 | 0 |
About Darian M. Bartkowski
Darian M. Bartkowski is a scholar working on Molecular Biology, Ophthalmology, Infectious Diseases, Organic Chemistry and Pathology and Forensic Medicine, having authored 6 papers that have together received 205 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (2 papers), Retinal Development and Disorders (2 papers), Epigenetics and DNA Methylation (1 paper), Melanoma and MAPK Pathways (1 paper), Quinazolinone synthesis and applications (1 paper), Cancer therapeutics and mechanisms (1 paper), Pneumonia and Respiratory Infections (1 paper) and Retinoids in leukemia and cellular processes (1 paper). The work is most often cited by research in Ophthalmology (35 citations), Clinical Biochemistry (15 citations), Hepatology (15 citations), Neurology (13 citations) and Immunology (30 citations). Darian M. Bartkowski has collaborated with scholars based in United States, China and Japan. Frequent co-authors include David C. Gale, Timothy S. Kern, Yunpeng Du, Liliana N. Berti‐Mattera, Michael R. Niesman, Gordon Alton, Jie Tang, Chieh Allen Lee, Mary E. Spilker and Justine L. Lam. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Nucleosides Nucleotides & Nucleic Acids, Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.